<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347.2020.14.1.15-24</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-621</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Pathogenetically differentiated management of pregnancy in patients with retrochorial hematoma</article-title><trans-title-group xml:lang="ru"><trans-title>Патогенетически дифференцированное ведение беременности у пациенток с ретрохориальной гематомой</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6192-1936</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Султангаджиева</surname><given-names>Х. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sultangadzhieva</surname><given-names>Kh. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Султангаджиева Хадижат Гасановна - аспирант кафедры акушерства и гинекологии Клинического института детского здоровья имени Н.Ф. Филатова.</p><p>119991 Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Khadizhat G. Sultangadzhieva - Postgraduate Student, Department of Obstetrics and Gynecology, Institute of Children’s Health.</p><p>Bild 2,8 Trubetskaya St., Moscow 119991</p></bio><email xlink:type="simple">sultangadzhieva90@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0725-9686</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хизроева</surname><given-names>Д. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Khizroeva</surname><given-names>J. Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джамиля Хизриевна Хизроева - доктор медицинских наук, профессор, профессор кафедры акушерства и гинекологии Клинического института детского здоровья имени Н.Ф. Филатова.</p><p>119991 Москва, ул. Трубецкая, д. 8, стр. 2</p></bio><bio xml:lang="en"><p>Jamilya Kh. Khizroeva - MD, Dr Sci Med, Professor, Department of Obstetrics and Gynecology, Institute of Children’s Health.</p><p>Bild 2,8 Trubetskaya St., Moscow 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>02</day><month>04</month><year>2020</year></pub-date><volume>14</volume><issue>1</issue><fpage>15</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Sultangadzhieva K.G., Khizroeva J.K., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Султангаджиева Х.Г., Хизроева Д.Х.</copyright-holder><copyright-holder xml:lang="en">Sultangadzhieva K.G., Khizroeva J.K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/621">https://www.gynecology.su/jour/article/view/621</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Intrauterine hematomas commonly found in routine ultrasound examinations represent one of causes resulting in early pregnancy loss. The most common is retrochorial hematoma resulting from fetal egg detachment from the uterine wall. Retrochorial hematoma often leads to pregnancy complications and affects gestational process.</p></sec><sec><title>Aim</title><p>Aim: to develop a personalized approach to the diagnosis, prevention and management of pregnancy with retrochorial hematomas in the early stages.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A prospective examination of 70 females, aged 22 to 37 years old, with retrochorial hematoma was performed at gestational age ranging from 5 to 12 weeks. Here, we examined serum level for lupus anticoagulant, antiphospholipid antibodies (AFA), antibodies to cardiolipin, fi2-glycoprotein I, to annexin V and prothrombin, and ADAMTS-13. All women were examined for genetic mutations linked to high thrombogenic risk and low thrombogenic risk polymorphisms. Patients were also examined for urinary tract infections.</p></sec><sec><title>Results</title><p>Results. It was found that 43 (61 %) females had aggravated obstetric anamnesis (non-developing pregnancy, spontaneous miscarriage in early stages, antenatal fetal death), whereas 13 (18.5 %) subjects had burdened familial thrombotic history (heart attack, stroke, and thrombosis occurred before the age of 55 years in first-line relatives). In addition, 22 (31.4 %) females were found to have genetic and acquired forms of thrombophilia; 6 (8.5 %) were detected to have circulatory ADAMTS-13 inhibitor; 5 females were confirmed to have decreased blood coagulation factor activity; and 38 (54.2 %) had vaginal dysbiosis.</p></sec><sec><title>Conclusion</title><p>Conclusion. Our work demonstrates that a personified and pathogenetically differentiated algorithm for diagnostics and management of pregnant women with chorionic detachments in early stages allows to lower frequency of early abortions and increases the therapeutic effectiveness.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. Одной из причин ранних потерь беременности являются внутриматочные гематомы, которые часто обнаруживаются при плановом ультразвуковом исследовании. Чаще всего встречается ретрохориальная гематома, которая является следствием отслойки плодного яйца от стенки матки и может приводить к осложнениям гестационного процесса. Цель исследования: разработка персонифицированного подхода к диагностике, профилактике и ведению беременности на ранних сроках у пациенток с ретрохориальными гематомами.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведено проспективное открытое интервенционное несравнительное исследование с участием 70 пациенток с ретрохориальной гематомой в возрасте от 22 до 37 лет в сроке беременности от 5 до 12 нед. Анализировали циркуляцию волчаночного антикоагулянта, наличие антифосфолипидных антител, антител к кардиолипину, в2-гли-копротеину I, к аннексину V и протромбину, фермент ADAMTS-13. Все женщины были обследованы на наличие генетических мутаций высокого тромбогенного риска и полиморфизмов низкого тромбогенного риска, а также на наличие инфекций урогенитального тракта.</p></sec><sec><title>Результаты</title><p>Результаты. У 43 (61 %) женщин наблюдался отягощенный акушерский анамнез (неразвивающаяся беременность, самопроизвольный выкидыш на ранних сроках, антенатальная гибель плода), а у 13 (18,5 %) пациенток - отягощенный семейный тромботический анамнез (наличие инфаркта, инсульта и тромбоза до 55 лет у родственников первой линии). У 22 (31,4 %) пациенток выявлены генетические и приобретенные формы тромбофилии; у 6 (8,5 %) пациенток обнаружена циркуляция ингибитора ADAMTS-13; у 5 женщин диагностировали снижение активности факторов свертывания; у 38 (54,2 %) женщин установлено нарушение биоценоза влагалища.</p></sec><sec><title>Заключение</title><p>Заключение. Персонифицированный и патогенетически дифференцированный алгоритм диагностики и ведения беременных с отслойками хориона на ранних сроках позволяет снизить частоту ранних потерь беременности и повышает эффективность лечения.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ретрохориальная гематома</kwd><kwd>ретрохориальное кровоизлияние</kwd><kwd>ведение и исходы беременности при ретрохориальной гематоме</kwd><kwd>выкидыш</kwd><kwd>низкомолекулярные гепарины</kwd><kwd>антифибринолитики</kwd></kwd-group><kwd-group xml:lang="en"><kwd>retrochorial hematoma</kwd><kwd>retrochorial hemorrhage</kwd><kwd>management and outcomes of pregnancy with retrochorial hematoma</kwd><kwd>miscarriage</kwd><kwd>low molecular weight heparins</kwd><kwd>antifibrinolytics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д., Бицадзе В.О., Баймурадова С.М. и др. Антифосфолипидный синдром - иммунная тромбофилия в акушерстве и гинекологии. Под ред. А.Д. Макацария. М.: Триада-Х, 2013. 485.</mixed-citation><mixed-citation xml:lang="en">Makatsariya A.D., Bitsadze V.O., Baimuradova S.M. et al. Antiphospholipid syndrome - the immune thrombophilia in obstetrics and gynecology. Ed. A.D. Makatsariya. [Antifosfolipidnyj sindrom -immunnaya trombofiliya v akusherstve i ginekologii. Pod red. A.D. Makatsariya]. Moskva: Triada-X, 2013. 485 s. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Norman S.M., Odibo A.O., Macones G.A. et al. Ultrasound-detected subchorionic hemorrhage and the obstetric implications. Obstet Gynecol. 2010;116(2 Pt 1):311-5. DOI: 10.1097/AOG.0b013e3181e90170.</mixed-citation><mixed-citation xml:lang="en">Norman S.M., Odibo A.O., Macones G.A. et al. Ultrasound-detected subchorionic hemorrhage and the obstetric implications. Obstet Gynecol. 2010;116(2 Pt 1):311-5. DOI: 10.1097/AOG.0b013e3181e90170.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Goldstein S.R., Subramanyam B.R., Raghavendra B.N. et al. Subchorionic bleeding in threatened abortion: sonographic findings and significance. AJR Am J Roentgenol. 1983;141(5):975-8. DOI: 10.2214/ajr.141.5.975.</mixed-citation><mixed-citation xml:lang="en">Goldstein S.R., Subramanyam B.R., Raghavendra B.N. et al. Subchorionic bleeding in threatened abortion: sonographic findings and significance. AJR Am J Roentgenol. 1983;141(5):975-8. DOI: 10.2214/ajr.141.5.975.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Султангаджиева Х.Г. Патогенез возникновения отслойки хориона и внутриматочных гематом на ранних сроках беременности: обзор современных научных данных. Акушерство, гинекология и репродукция. 2019;13(4):354-68. DOI: 10.17749/2313-7347.2019.13.4.354-368.</mixed-citation><mixed-citation xml:lang="en">Sultangadzhieva K.G. Pathogenesis of chorionic detachment and intrauterine hematomas in early pregnancy: a literature review. [Patogenez vozniknoveniya otslojki horiona i vnutrimatochnyh gematom na rannih srokah beremennosti: obzor sovremennyh nauchnyh dannyh]. Akusherstvo, ginekologiya ireprodukciya. 2019;13(4):354-68. (In Russ.). DOI: 10.17749/2313-7347.2019.13.4.354-368.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Бицадзе В.О., Хизроева Д.Х., Макацария Н.А. и др. Антифосфолипидные антитела, их патогенетическое и диагностическое значение при акушерской патологии. Акушерство, гинекология и репродукция. 2014;8(2):39-60.</mixed-citation><mixed-citation xml:lang="en">Bitsadze V.O., Khizroeva D.Kh., Makatsariya N.A. et al. Antiphospholipid antibodies, their pathogenetic and diagnostic issues in obstetric practice. [Antifosfolipidnye antitela, ih patogeneticheskoe i diagnostich-eskoe znachenie pri akusherskoj patologii]. Akusherstvo, ginekologiya ireprodukciya. 2014;8(2):39—60. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Potdar N., Gelbaya T.A., Konje J.C., Nardo L.G. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(6):674-84. DOI: 10.1093/humupd/dmt032.</mixed-citation><mixed-citation xml:lang="en">Potdar N., Gelbaya T.A., Konje J.C., Nardo L.G. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(6):674-84. DOI: 10.1093/humupd/dmt032.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol. 2012;28(12):983-90. DOI: 10.3109/09513590.2012.702875.</mixed-citation><mixed-citation xml:lang="en">Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage. Gynecol Endocrinol. 2012;28(12):983-90. DOI: 10.3109/09513590.2012.702875.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Coomarasamy A., Devall A.J., Cheed V. et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N Engl J Med. 2019;380(19):1815-24. DOI: 10.1056/NEJMoa1813730.</mixed-citation><mixed-citation xml:lang="en">Coomarasamy A., Devall A.J., Cheed V. et al. A randomized trial of progesterone in women with bleeding in early pregnancy. N Engl J Med. 2019;380(19):1815-24. DOI: 10.1056/NEJMoa1813730.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Peitsidis P., Kadir R.A. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12(4):503-16. DOI: 10.1517/14656566.2011.545818.</mixed-citation><mixed-citation xml:lang="en">Peitsidis P., Kadir R.A. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12(4):503-16. DOI: 10.1517/14656566.2011.545818.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D., Luo Z.Y., Yu Z.P. et al. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial. J Thromb Haemost. 2018;16(12):2442-53. DOI: 10.1111/jth.14316.</mixed-citation><mixed-citation xml:lang="en">Wang D., Luo Z.Y., Yu Z.P. et al. The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial. J Thromb Haemost. 2018;16(12):2442—53. DOI: 10.1111/jth.14316.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ковалева В.Ю. Ретрохориальная гематома. Вопросы этиопатоге-неза, диагностики и терапии. Журнал акушерства и женских болезней. 2013;62(4):37-47.</mixed-citation><mixed-citation xml:lang="en">Kovalyova J.V. Subchorionic hematoma. Causes, pathogenesis, diagnostic and treatment management. [Retrohorial’naya gematoma. Voprosy etiopatogeneza, diagnostiki i terapii]. Zhurnalakusherstva i zhenskih boleznej. 2013;62(4):37—47. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Бицадзе В.О., Макацария А.Д. Применение низкомолекулярных гепаринов в акушерской практике. РМЖ. 2000;8(18):772-7.</mixed-citation><mixed-citation xml:lang="en">Bitsadze V.O., Makatsariya A.D. Use of low molecular weight heparins in obstetric practice. [Primenenie nizkomolekulyarnyh geparinov v akusherskoj praktike]. RMZh. 2000;8(18):772-7. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Хизроева Д.Х. Антифосфолипидный синдром и неудачи экстракорпорального оплодотворения. Практическая медицина. 2013;(6):154-60.</mixed-citation><mixed-citation xml:lang="en">Khizroeva D.Kh. Antiphospholipid syndrome and failures of extracorporal fertilization. [Antifosfolipidnyj sindrom i neudachi ekstrakorporal’nogo oplodotvoreniya]. Prakticheskaya medicina. 2013;(6):154—60. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">De Sancho M.T., Khalid S., Christos P.J. Outcomes in women receiving low-molecular-weight heparin during pregnancy. Blood Coagul Fibrinolysis. 2012;23(8):751-55. DOI: 10.1097/MBC.0b013e328358e92c.</mixed-citation><mixed-citation xml:lang="en">De Sancho M.T., Khalid S., Christos P.J. Outcomes in women receiving low-molecular-weight heparin during pregnancy. Blood Coagul Fibrinolysis. 2012;23(8):751-55. DOI: 10.1097/MBC.0b013e328358e92c.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rodger M.A., Gris J.C., de Vries J.I.P. et al; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Lancet. 388(10060):2629-41. DOI: 10.1016/S0140-6736(16)31328-9.</mixed-citation><mixed-citation xml:lang="en">Rodger M.A., Gris J.C., de Vries J.I.P. et al; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Lancet. 388(10060):2629-41. DOI: 10.1016/S0140-6736(16)31328-9.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Nagy S., Bush M., Stone J. et al. Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet Gynecol. 2003;102(1):94-100. DOI: 10.1016/s0029-7844(03)00403-4.</mixed-citation><mixed-citation xml:lang="en">Nagy S., Bush M., Stone J. et al. Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet Gynecol. 2003;102(1):94-100. DOI: 10.1016/s0029-7844(03)00403-4.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Palatnik A., Grobman W.A. The relationship between first-trimester subchorionic hematoma, cervical length, and preterm birth. Am J Obstet Gynecol. 2015;213(3):403.e1-4. DOI: 10.1016j.ajog.2015.05.019.</mixed-citation><mixed-citation xml:lang="en">Palatnik A., Grobman W.A. The relationship between first-trimester subchorionic hematoma, cervical length, and preterm birth. Am J Obstet Gynecol. 2015;213(3):403.e1-4. DOI: 10.1016/j.ajog.2015.05.019.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Seki H., Kuromaki K., Takeda S., Kinoshita K. Persistent subchorionic hematoma with clinical symptoms until delivery. Int J Gynaecol Obstet. 1998;63(2):123-8. DOI: 10.1016/s0020-7292(98)00153-2.</mixed-citation><mixed-citation xml:lang="en">Seki H., Kuromaki K., Takeda S., Kinoshita K. Persistent subchorionic hematoma with clinical symptoms until delivery. Int J Gynaecol Obstet. 1998;63(2):123-8. DOI: 10.1016/s0020-7292(98)00153-2.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ozkaya E., Altay M., Gelisen O. Significance of subchorionic haemorrhage and pregnancy outcome in threatened miscarriage to predict miscarriage, pre-term labour and intrauterine growth restriction. J Obstet Gynaecol. 2011;31(3):210-2. DOI: 10.3109/01443615.2010.545899.</mixed-citation><mixed-citation xml:lang="en">Ozkaya E., Altay M., Gelisen O. Significance of subchorionic haemorrhage and pregnancy outcome in threatened miscarriage to predict miscarriage, pre-term labour and intrauterine growth restriction. J Obstet Gynaecol. 2011;31(3):210-2. DOI: 10.3109/01443615.2010.545899.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
